Biotech Spotlight: Actinium Pharmaceticals ATNM

Actinium Pharmaceuticals, Inc. (ATNM: NYSE MKT) is an open biopharmaceutical organization with expertise in the improvement of disease medications. The Company’s products are licensed technology co-created with Memorial Sloan Kettering Cancer Center (MSKCC) for linking the disease focusing on accuracy of monoclonal antibodies (mAb) for focusing on particular sorts of cells with the force of alpha radiating radioisotopes, the most intense growth executing agents that exist. ATNM’s first medication for the…

July 20, 2015